Panacea Biotec Pharma Limited Lactulose Export Data — India (DGFT 2022–2026)

Name: Panacea Biotec Pharma Limited Lactulose Export Records India — #3 Exporter, 47 Shipments, $1.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lactulose

India Pharmaceutical Trade Intelligence

$13.4M154 Suppliers90 CountriesHS 30049099

ExportsIndia → SRI LANKA34.9%India → TANZANIA14.0%

ImportsCANADA → India$4.0B SOUTH AFRICA → India$56.8K

#1 Supplier: STERLING LAB,

Panacea Biotec Pharma Limited — Lactulose Exporter #3 | $1.2M Trade Value | TransData Nexus | TransData Nexus

Panacea Biotec Pharma Limited — Lactulose Exporter Profile

Indian Pharmaceutical Exporter · #3 for Lactulose · $1.2M export value · DGFT Verified

Panacea Biotec Pharma Limited is the #3 Indian exporter of Lactulose with $1.2M in export value and 47 verified shipments. Panacea Biotec Pharma Limited holds a 9.0% market share in Lactulose exports across 11 countries. The company exports 13 pharmaceutical products worth $23.9M across 9 therapeutic categories.

Panacea Biotec Pharma Limited — Lactulose Export Profile: Buyers & Destinations

Panacea Biotec Pharma Limited Lactulose export treemap — buyers and destination countries | TransData Nexus

Where Does Panacea Biotec Pharma Limited Export Lactulose?

Country	Value	Shipments	Share
PANAMA	$692.6K	15	61.6%
PHILIPPINES	$87.8K	4	7.8%
KENYA	$74.6K	6	6.6%
TANZANIA	$61.5K	5	5.5%

Who Are the Top Buyers of Lactulose from Panacea Biotec Pharma Limited?

Buyer	Country	Value	Orders
NUTRIMED PANAMA S.A.,	PANAMA	$338.6K	7
NUTRIMED PANAMA S A	PANAMA	$336.9K	7
NATIONAL PHYTOPHARMA JOINT STOCK	VIETNAM, DEMOCRATIC REP. OF	$70.0K	3
GENERICS & SPECIALITIES LIMITED	TANZANIA	$61.5K	5
RIGHT & BRIGHT INTERNATIONAL	MYANMAR	$53.8K	2
MEDINOVA PHARMACEUTICAL INC.	PHILIPPINES	$45.0K	3
MEDINOVA PHARMACEUTICAL INC	PHILIPPINES	$42.8K	1
PRIME BANK LIMITED	KENYA	$33.6K	1
RIGHT & BRIGHT INTERNATIONAL COMPAN	MYANMAR	$24.2K	1
NATIONAL PHYTOPHARMA JOINT STOCK CO	VIETNAM, DEMOCRATIC REP. OF	$20.1K	3

Panacea Biotec Pharma Limited supplies Lactulose to 20 buyers globally. The largest buyer is NUTRIMED PANAMA S.A., (PANAMA), followed by NUTRIMED PANAMA S A (PANAMA) and NATIONAL PHYTOPHARMA JOINT STOCK (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Lactulose Formulations Does Panacea Biotec Pharma Limited Export?

Product Description / Formulation	Value	Shipments
LACTULOSE SOLUTION USP 10G/15ML-LACTULOSE 10G AS LACTULOSE CONCENTRATE USP PALATABLE BASE Q.S.DETAIL AS PER DOCUMENT	$100.0K	2
LACTULOSE SOLUTION USP 10G/15ML BATCH NO 52623017 TO 52623020 MFG DT 10/2023 EXP DT 09/2026 OTHER DTLS AS INVOICE	$50.0K	1
LACTULOSE SOLUTION USP 10G/15ML BATCH NO 52623013 TO 52623016 MFG DT 10/2023 EXP DT 09/2026 OTHER DTLS AS PER INVOICE	$50.0K	1
LACTULOSE SOLUTION USP 10G/15ML BATCH NO 52623025 TO 52623029 MFG DT 11/2023 EXP DT 10/2026 OTHER DTLS AS PER INVOICE	$50.0K	1
LACTULOSE SOLUTION USP 10G/15ML BATCH NO 52623021 TO 52623024 MFG DT 11/2023 EXP DT 10/2026 OTHER DTLS AS PER INVOICE	$50.0K	1
LACTULOSE SOLUTION USP 10G/15ML BATCH NO. 52624001 TO 52624005 MFG. DATE - 06/2024 EXP. DT - 05/2027 AS PER INV AND PL	$50.0K	1
LACTULOSE SOLUTION USP 10G/15ML BATCH NO. 52624010 TO 52624015 MFG. DATE - 07/2024 EXP. DT - 06/2027 AS PER INV AND PL	$50.0K	1
LACTULOSE SLUTN USP10G/15ML BCHNO.52624006TO52624009MFG.DT-6/24 EXP.DT-5/27 BN.52624010MFG.DT-7/24 EX-6/27 AS PER INV&PL	$50.0K	1
LACTULOSE SOLUTION USP 10G/15ML BATCH NO. 52624020 TO 52624024 MFG. DATE - 07/2024 EXP. DT - 06/2027 AS PER INV AND PL	$50.0K	1
LACTULOSE SOLUTION USP 10G/15ML BATCH NO. 52624015 TO 52624019 MFG. DATE - 07/2024 EXP. DT - 06/2027 AS PER INV AND PL	$50.0K	1

Panacea Biotec Pharma Limited exports 36 distinct Lactulose formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LACTULOSE SOLUTION USP 10G/15ML-LACTULOSE 10G AS LACTULOSE C with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Panacea Biotec Pharma Limited Compare to Nearest Lactulose Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	PANACEA BIOTEC PHARMA LIMITED ★	$1.2M	47	11	$25.9K
4	SANPRAS HEALTHCARE PRIVATE LIMITED	$1.1M	40	2	$26.8K
1	STERLING LAB,	$950.0K	19	1	$50.0K

Panacea Biotec Pharma Limited ranks #3 among 154 Indian Lactulose exporters. Average shipment value of $25.9K compared to the market average of $40.3K. The closest competitors by value are SANPRAS HEALTHCARE PRIVATE LIMITED and STERLING LAB,.

Which Indian Ports Ship Lactulose Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	140	14.6%
SAHAR AIR	119	12.4%
NHAVA SHEVA SEA (INNSA1)	95	9.9%
JNPT/ NHAVA SHEVA SEA	47	4.9%
Bombay Air	30	3.1%
JNPT	30	3.1%
DELHI AIR	27	2.8%
CHENNAI SEA (INMAA1)	25	2.6%

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Lactulose Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Panacea Biotec. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential delays. These maritime disruptions are particularly concerning for time-sensitive pharmaceutical shipments, as extended transit times and congestion elevate the risk of cold-chain failures for vaccines and biologics. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced uncertainties for Indian exporters. While health products have been exempt from U.S. tariffs, there is growing concern that this exemption may not be permanent. The potential imposition of tariffs on pharmaceutical imports could impact Panacea Biotec's profitability, given the company's significant export volume to the U.S. market. (lemonde.fr)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. This shift presents an opportunity for Panacea Biotec to expand its footprint in the U.S. market, provided it can navigate the evolving regulatory and trade environment effectively.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The recent GMP non-compliance issue at Panacea Biotec's Baddi facility underscores the importance of adhering to stringent EU regulations. Addressing these compliance challenges promptly is essential to maintain and grow the company's presence in European markets.

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency (EMA) enforcing stringent quality standards. For Indian exporters, maintaining compliance with these standards is paramount to ensure uninterrupted market access.

Panacea Biotec's recent GMP non-compliance at its Baddi facility highlights the critical need for robust quality management systems. The company has committed to implementing comprehensive corrective and preventive actions and plans to request a re-inspection to reinstate its GMP certificates. (prysm.fi) Proactive measures in quality assurance will be vital for Panacea Biotec to rebuild trust with regulatory bodies and international clients.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lactulose shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Panacea Biotec Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 47 individual customs records matching Panacea Biotec Pharma Limited exporting Lactulose, covering 36 formulations to 12 countries via 20 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 90+ countries, 359+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lactulose

Lactulose

Panacea Biotec Pharma Limited — Lactulose Exporter Profile

Panacea Biotec Pharma Limited — Lactulose Export Profile: Buyers & Destinations

Where Does Panacea Biotec Pharma Limited Export Lactulose?

Who Are the Top Buyers of Lactulose from Panacea Biotec Pharma Limited?

What Is India's Total Lactulose Export Value and How Much Does Panacea Biotec Pharma Limited Contribute?

What Is the Average Shipment Value for Panacea Biotec Pharma Limited's Lactulose Exports?

How Does Panacea Biotec Pharma Limited Compare to Other Indian Lactulose Exporters?

What Lactulose Formulations Does Panacea Biotec Pharma Limited Export?

How Does Panacea Biotec Pharma Limited Compare to Nearest Lactulose Exporters?

Which Indian Ports Ship Lactulose Exports?

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Lactulose Exports

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

About Panacea Biotec Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lactulose Export Data from Panacea Biotec Pharma Limited

Lactulose Stats

Company Overview

Top Products by Panacea Biotec Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source